A detailed history of Northwestern Mutual Wealth Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 182,772 shares of BMY stock, worth $10.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
182,772
Previous 179,840 1.63%
Holding current value
$10.6 Million
Previous $7.47 Million 26.65%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $116,283 - $151,731
2,932 Added 1.63%
182,772 $9.46 Million
Q2 2024

Aug 15, 2024

SELL
$40.25 - $52.99 $438,483 - $577,273
-10,894 Reduced 5.71%
179,840 $7.47 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $291,862 - $330,915
-6,083 Reduced 3.09%
190,734 $10.3 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $1.12 Million - $1.33 Million
-23,069 Reduced 10.49%
196,817 $10.1 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $553,891 - $619,336
9,568 Added 4.55%
219,886 $12.8 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $100,406 - $111,486
1,576 Added 0.75%
210,318 $13.4 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $204,292 - $231,713
-3,109 Reduced 1.47%
208,742 $14.5 Million
Q4 2022

Feb 21, 2023

BUY
$68.48 - $81.09 $248,650 - $294,437
3,631 Added 1.74%
211,851 $15.2 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $752 - $444,903
-5,790 Reduced 2.71%
208,220 $14.8 Million
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $60,129 - $66,223
-828 Reduced 0.39%
214,010 $16.5 Million
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $1.47 Million - $1.76 Million
-23,923 Reduced 10.02%
214,838 $15.7 Million
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $309,605 - $360,927
5,773 Added 2.48%
238,761 $14.9 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $247,448 - $289,854
4,182 Added 1.83%
232,988 $13.8 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $670,051 - $729,686
10,823 Added 4.97%
228,806 $15.3 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $627,401 - $705,642
10,573 Added 5.1%
217,983 $13.8 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $4,561 - $5,168
-79 Reduced 0.04%
207,410 $12.9 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $177,516 - $196,711
-3,091 Reduced 1.47%
207,489 $12.5 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $965,873 - $1.13 Million
17,619 Added 9.13%
210,580 $12.4 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $140,035 - $203,503
3,018 Added 1.59%
192,961 $10.8 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $2.18 Million - $2.84 Million
44,213 Added 30.34%
189,943 $12.2 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $137,120 - $162,576
3,206 Added 2.25%
145,730 $7.39 Million
Q2 2019

Aug 12, 2019

SELL
$44.62 - $49.34 $369,810 - $408,929
-8,288 Reduced 5.5%
142,524 $6.46 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $395,341 - $471,395
8,762 Added 6.17%
150,812 $7.2 Million
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $530,752 - $688,258
10,885 Added 8.3%
142,050 $7.38 Million
Q3 2018

Nov 01, 2018

BUY
$55.19 - $62.25 $427,556 - $482,250
7,747 Added 6.28%
131,165 $8.14 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $117,381 - $146,302
2,323 Added 1.92%
123,418 $6.83 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $933,313 - $1.07 Million
15,576 Added 14.76%
121,095 $7.66 Million
Q4 2017

Jan 31, 2018

BUY
$59.94 - $65.35 $49,030 - $53,456
818 Added 0.78%
105,519 $6.47 Million
Q3 2017

Nov 07, 2017

BUY
$55.23 - $63.74 $358,774 - $414,055
6,496 Added 6.61%
104,701 $6.67 Million
Q2 2017

Aug 10, 2017

BUY
N/A
98,205
98,205 $5.47 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.